JP2024530956A5 - - Google Patents

Info

Publication number
JP2024530956A5
JP2024530956A5 JP2024508668A JP2024508668A JP2024530956A5 JP 2024530956 A5 JP2024530956 A5 JP 2024530956A5 JP 2024508668 A JP2024508668 A JP 2024508668A JP 2024508668 A JP2024508668 A JP 2024508668A JP 2024530956 A5 JP2024530956 A5 JP 2024530956A5
Authority
JP
Japan
Prior art keywords
group
groups
alkyl
cancer
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024508668A
Other languages
English (en)
Japanese (ja)
Other versions
JP7863914B2 (ja
JP2024530956A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/112259 external-priority patent/WO2023016562A1/zh
Publication of JP2024530956A publication Critical patent/JP2024530956A/ja
Publication of JP2024530956A5 publication Critical patent/JP2024530956A5/ja
Application granted granted Critical
Publication of JP7863914B2 publication Critical patent/JP7863914B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024508668A 2021-08-12 2022-08-12 多環式系化合物およびその使用 Active JP7863914B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN202110926274 2021-08-12
CN202110926274.3 2021-08-12
CN202111485631.3 2021-12-07
CN202111485631 2021-12-07
CN202210624529 2022-06-02
CN202210624529.5 2022-06-02
PCT/CN2022/112259 WO2023016562A1 (zh) 2021-08-12 2022-08-12 多环类化合物及其用途

Publications (3)

Publication Number Publication Date
JP2024530956A JP2024530956A (ja) 2024-08-27
JP2024530956A5 true JP2024530956A5 (cg-RX-API-DMAC7.html) 2025-05-19
JP7863914B2 JP7863914B2 (ja) 2026-05-22

Family

ID=85199846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508668A Active JP7863914B2 (ja) 2021-08-12 2022-08-12 多環式系化合物およびその使用

Country Status (8)

Country Link
US (1) US20250154105A1 (cg-RX-API-DMAC7.html)
EP (1) EP4385978A4 (cg-RX-API-DMAC7.html)
JP (1) JP7863914B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240046891A (cg-RX-API-DMAC7.html)
CN (1) CN117677608A (cg-RX-API-DMAC7.html)
AU (1) AU2022326724B2 (cg-RX-API-DMAC7.html)
CA (1) CA3228542A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023016562A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7739051B2 (ja) 2020-06-10 2025-09-16 アムジエン・インコーポレーテツド シクロブチルジヒドロキノリンスルホンアミド化合物
KR20240138099A (ko) * 2022-01-26 2024-09-20 쑤저우 젠하우스 바이오 컴퍼니 리미티드 Mtap 결실 암을 치료하기 위한 메티오닌 아데노실트랜스퍼라제 2a 억제제
EP4759814A1 (en) * 2023-08-11 2026-06-17 SK Biopharmaceuticals Co., Ltd. Tricyclic compound and use thereof as mat2a inhibitor
CN117327007B (zh) * 2023-09-26 2024-09-13 上海陶术生物科技有限公司 一种vt107的制备方法
CN122138965A (zh) * 2023-11-21 2026-06-02 上海同源康医药有限公司 苯并五元杂环类衍生物及其应用
CN119528810B (zh) * 2024-12-09 2025-04-29 山东第一医科大学(山东省医学科学院) 喹啉类化合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5433594A (en) * 1992-11-19 1994-06-08 Dainippon Pharmaceutical Co. Ltd. 3,4-dihydro-1-(2-hydroxyphenyl)-2(1h)-quinoxalinone derivative and related compound
JPH07145152A (ja) * 1992-11-19 1995-06-06 Dainippon Pharmaceut Co Ltd 3,4−ジヒドロ−1−(2−ヒドロキシフェニル)−2(1h)−キノキサリノン誘導体及び関連化合物
WO1996006843A1 (en) * 1994-08-29 1996-03-07 Yamanouchi Pharmaceutical Co., Ltd. Novel naphthyridine derivative and medicinal composition thereof
ATE261445T1 (de) * 1999-12-08 2004-03-15 Grelan Pharmaceutical Co Neue 1,8-naphtyridin-2(1h)-on-derivate
CN1325481C (zh) * 2002-12-31 2007-07-11 中国人民解放军63971部队 含喹喔啉酮结构的方酸菁染料
CN1774247A (zh) * 2003-02-14 2006-05-17 史密丝克莱恩比彻姆公司 新的化合物
US9212182B2 (en) * 2013-06-12 2015-12-15 Amgen Inc. Bicyclic sulfonamide compounds as sodium channel inhibitors
WO2016022915A1 (en) * 2014-08-08 2016-02-11 The Regent Of The University Of California 6-sulfonylamino quinoline compounds as plant growth regulators
MY197595A (en) * 2015-12-18 2023-06-27 Amgen Inc Alkyl dihydroquinoline sulfonamide compounds
WO2017106872A1 (en) * 2015-12-18 2017-06-22 Amgen Inc Alkynyl dihydroquinoline sulfonamide compounds
CN108658937A (zh) * 2017-03-28 2018-10-16 中国海洋大学 一种双环生物碱类化合物及其制备方法和应用
EP3643711A1 (en) * 2018-10-24 2020-04-29 Bayer Animal Health GmbH New anthelmintic compounds
EP3877356A4 (en) 2018-11-09 2022-06-22 Vivace Therapeutics, Inc. BICYCLIC LINKS
JP2022525186A (ja) * 2019-03-15 2022-05-11 ザ ジェネラル ホスピタル コーポレイション Tead転写因子新規小分子阻害剤
BR112021024108A2 (pt) * 2019-05-31 2022-03-22 Ikena Oncology Inc Inibidores de tead e usos dos mesmos
AR119046A1 (es) * 2019-05-31 2021-11-17 Agios Pharmaceuticals Inc Inhibidores heterobicíclicos de mat2a y su uso para el tratamiento de diversos tipos de cáncer
JP7879815B2 (ja) * 2020-06-10 2026-06-24 アムジエン・インコーポレーテツド ヘテロアルキルジヒドロキノリンスルホンアミド化合物
JP7880201B2 (ja) * 2020-06-10 2026-06-25 アムジエン・インコーポレーテツド シクロプロピルジヒドロキノリンスルホンアミド化合物
JP7739051B2 (ja) * 2020-06-10 2025-09-16 アムジエン・インコーポレーテツド シクロブチルジヒドロキノリンスルホンアミド化合物
CN113372184B (zh) * 2021-03-26 2023-08-18 武汉大学 一种基于手性转移策略合成c–n轴手性菲啶酮类化合物的方法

Similar Documents

Publication Publication Date Title
RU2448096C2 (ru) Диарилгидантоины
JP2020517616A5 (cg-RX-API-DMAC7.html)
RU2011152891A (ru) Диарилгидантоины
JP2024522766A5 (cg-RX-API-DMAC7.html)
ES2911040T3 (es) Nuevos derivados de heteroaril amida como inhibidores selectivos de histona deacetilasa 1 y 2 (HDAC1/2)
JP2009515988A5 (cg-RX-API-DMAC7.html)
JP2007511504A5 (cg-RX-API-DMAC7.html)
JP2008528468A5 (cg-RX-API-DMAC7.html)
JP2009541223A5 (cg-RX-API-DMAC7.html)
RU2005140570A (ru) Фармацевтическая композиция, содержащая ингибитор гистондеацетилазы
JP2009515980A5 (cg-RX-API-DMAC7.html)
JP2011509949A5 (cg-RX-API-DMAC7.html)
RU2005133994A (ru) Оксимные производные и их применение в качестве фармацевтически активных агентов
CN102838590A (zh) 氨基喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途
JP2016508135A5 (cg-RX-API-DMAC7.html)
AU2019331665A1 (en) Heterocyclic compounds as AHR modulators
JP2014524449A5 (cg-RX-API-DMAC7.html)
JP2013530130A (ja) ヘテロアリール(アルキル)ジチオカルバメート化合物、その調製方法及び使用
JP2021536472A5 (cg-RX-API-DMAC7.html)
JP2016501254A (ja) がん、ウイルス感染症、及び肺疾患の処置のためのインドールの新規誘導体
CN105050602B (zh) 作为pi3激酶抑制剂的吡啶化合物
JP2006518726A5 (cg-RX-API-DMAC7.html)
RU2004111787A (ru) Ретиноидные агонисты (1), производные алкилмочевины
RU2017108909A (ru) Производные изохинолинона, полезные для лечения рака
JP2004518633A5 (cg-RX-API-DMAC7.html)